HALO

HALOZYME THERAPEUTICS INC

Healthcare | Mid Cap

$1.16

EPS Forecast

$298.2

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon

Market expectations

EPS Expectation:

$1.16

Revenue Expectation:

$298.2

EPS Surprise Expectation:

$0.065

Revenue Surprise Expectation:

$7

Post-release price volatility - Medium

Post-release Overnight Move:

±6.7%

Post-release 1-week Move:

Expected price impact

If company results match EPS & revs consensus exactly:

If company results match Proximilar expectations exactly:

Earnings volatility

EPS standard deviation:

Revenue standard deviation: